Investment
Features
FeesSafety
Academy
More
Pluang+

Nanox reports Q3 2026 revenue rise to $4.3-$4.4M but warns cash may not last a year.

Company Fundamentals
16 Oct 2026
GlobeNewsWire
View Source
Bullish
Nanox reports Q3 2026 revenue rise to $4.3-$4.4M but warns cash may not last a year.

Nanox Imaging Ltd provided a business update and preliminary unaudited financial data for Q3 2026, reporting estimated revenue of $4.3 to $4.4 million, up from $3.4 million in Q3 2025. Revenue growth was driven mainly by AI and software solutions, which increased to $1.0 million from $0.1 million, and a slight increase in imaging system sales. However, the company’s cash and equivalents fell to approximately $26 million as of September 30, 2026, down from $60 million at the end of 2025, raising concerns about its ability to continue operations for at least one year without additional funding. Nanox also announced a distribution agreement in Italy for its AI Bone Solution and recognition by TIME as one of the best inventions of 2026 for its Nanox.ARC X system. The company cautions that final financial results may differ and highlighted risks related to liquidity and ongoing operations.

Nanox's recent business update and preliminary Q3 2026 financial data provide context for readers. For those following the health sector, here is Pluang's market snapshot as of Oct 17, 2026 03:11 WIB: out of 150 priced health stocks, 52 rose and 98 fell. Notable movers include ERAS at USD 13.45 with a -9.58% change and a typical hold time of 2 days, WGS at USD 63.51 down 9.56% with 100% sell order activity and a 20-day hold, and SANA at USD 2.25 down 8.89% with 99% buy order activity and a 24-day hold.

More News

Northland Power sets Q3 2026 earnings release for Nov 12 with a call on Nov 13

Northland Power sets Q3 2026 earnings release for Nov 12 with a call on Nov 13

Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...

Company Fundamentals
Neutral
58 minutes ago
Daily leveraged ETFs plunge over 20% amid sharp losses in underlying stocks

Daily leveraged ETFs plunge over 20% amid sharp losses in underlying stocks

Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...

Market News
Bearish
58 minutes ago
Biotech IPOs and inverse ETFs lead market gains with strong debut and leveraged moves.

Biotech IPOs and inverse ETFs lead market gains with strong debut and leveraged moves.

Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...

Market News
Bullish
58 minutes ago
Constellation Software schedules Q3 results call for Nov 9 after TSX closes Nov 6

Constellation Software schedules Q3 results call for Nov 9 after TSX closes Nov 6

Constellation Software Inc. announced it will release its third quarter financial results on November 6, 2026, after the Toronto Stock Exchange closes. The company will hold a conference call and live webcast on November 9, 2026, at 8:00 a.m. ET, whe...

Company Fundamentals
Neutral
1 hour ago
Topicus.com to release Q3 2026 financial results on November 4 after market close

Topicus.com to release Q3 2026 financial results on November 4 after market close

Topicus.com Inc. announced it will publish its third quarter financial results for 2026 on November 4, after the market closes. The results will be available via press release on the company's website and the SEDAR platform. This update follows recen...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App